Mark Schmidt, MD
Urology · Roanoke, VANPI 1023000684
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $81,250 of the $83,702 with a category attached, or 97.1%. Roanoke Area Surgical Lasers, LLC accounts for 97.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $30,048 and has fallen 99.9% since, to $35 in 2025. Among urology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 149 payments — averaging $561.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roanoke Area Surgical Lasers, LLC$81K
- Coloplast$797
- Astellas Pharma US Inc$714
- Pfizer$512
- Myovant Sciences Inc.$118
- Johnson & Johnson$68
- plus $243 from 8 others
What the payments were for
- Food & beverage$2,4033%
- Education$500%
- Ownership interest$81,25097%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roanoke Area Surgical Lasers, LLC | 4 | $81,250 |
| Coloplast | 47 | $797 |
| Astellas Pharma US Inc | 41 | $714 |
| Pfizer | 35 | $512 |
| Myovant Sciences Inc. | 7 | $118 |
| Johnson & Johnson | 3 | $68 |
| Tolmar Pharmaceuticals, Inc. | 2 | $47 |
| AbbVie(2 entities) | 3 | $46 |
| AstraZeneca | 1 | $35 |
| Bayer | 2 | $32 |
| Blue Earth Diagnostics | 1 | $26 |
| Urogen Pharma, Inc. | 1 | $24 |
| Amgen | 1 | $22 |
| Boston Scientific | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPEEDICATH$140
- Luja Coude$135
How this compares
$83,702 in reported general payments places this provider in the 95th percentile of 300 urology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 340 | $300,779 |
| Methenamine Hippurate | 195 | $24,225 |
| Finasteride | 1,049 | $12,883 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 771 | $12,605 |
| Tamsulosin Hcl | 853 | $9,953 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 53 | $6,589 |
| Estradiol | 73 | $4,520 |
| Testosterone | 22 | $4,464 |
| Solifenacin Succinate | 55 | $4,198 |
| PremarinEstrogens, Conjugated | 14 | $4,029 |
| Dutasteride | 61 | $2,845 |
| Bicalutamide | 86 | $2,580 |
| Silodosin | 12 | $2,096 |
| Trospium Chloride ErTrospium Chloride | 11 | $1,791 |
| Potassium Citrate ErPotassium Citrate | 11 | $1,388 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $714 | $300,779340 claims |
| PfizerPremarin | $512 | $4,02914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 300 urology providers in Virginia.
Other urology in Roanoke
- Charles DanielRoanoke$94K
- David KageyRoanoke$90K
- Rodney PoffenbergerRoanoke$85K
- Robert WhisnantRoanoke$84K
- Yu ZhangRoanoke$34K
- Michael FabrizioVirginia Beach$1.5M
- Gregg EureVirginia Beach$1.4M
- Jessica DelongVirginia Beach$578K
- Robert GivenVirginia Beach$157K
- Michael WilliamsVirginia Beach$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.